Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:967:227-240.
doi: 10.1007/978-3-319-63245-2_13.

Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology

Dhara Patel  1 , Anand Lakhkar  1 , Michael S Wolin  2
Affiliations

Redox Mechanisms Influencing cGMP Signaling in Pulmonary Vascular Physiology and Pathophysiology

Dhara Patel et al. Adv Exp Med Biol. 2017.

Abstract

The soluble form of guanylate cyclase (sGC) and cGMP signaling are major regulators of pulmonary vasodilation and vascular remodeling that protect the pulmonary circulation from hypertension development. Nitric oxide, reactive oxygen species, thiol and heme redox, and heme biosynthesis control mechanisms regulating the production of cGMP by sGC. In addition, a cGMP-independent mechanism regulates protein kinase G through thiol oxidation in manner controlled by peroxide metabolism and NADPH redox. Multiple aspects of these regulatory processes contribute to physiological and pathophysiological regulation of the pulmonary circulation, and create potentially novel therapeutic targets for the treatment of pulmonary vascular disease.

Keywords: Cyclic guanosine monophosphate; Heme redox; NADPH oxidase; Nitric oxide; Protein kinase G; Pulmonary vascular disease; Reactive oxygen species; Soluble guanylate cyclase; Thiol oxidation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
cGMP-related signaling mechanisms regulating pulmonary vascular relaxation and remodeling.
Fig. 2
Fig. 2
Nitric oxide, reactive oxygen species, thiol and heme redox, and heme biosynthesis control mechanisms that regulate the production of cGMP by sGC and/or a cGMP-independent mechanism regulating protein kinase G.
Fig. 3
Fig. 3
Therapeutic targeting of cGMP signaling for the treatment of pulmonary vascular disease.
See this image and copyright information in PMC

References

    1. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39(3):163–196. - PubMed
    1. Craven PA, DeRubertis FR. Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. J Biol Chem. 1978;253(23):8433–8443. - PubMed
    1. Ignarro LJ, Lippton H, Edwards JC, et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther. 1981;218(3):739–749. - PubMed
    1. Ignarro LJ, Burke TM, Wood KS, et al. Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther. 1984;228(3):682–690. - PubMed
    1. Ignarro LJ, Buga GM, Wood KS, et al. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84(24):9265–9269. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources